Health
New staging system can inform treatment decisions for non-metastatic prostate cancer – News-Medical.Net
Doctors and biostatisticians at the University of Michigan Rogel Cancer Center have led the development and validation of a staging system to better predict outcomes…
Reviewed by Emily Henderson, B.Sc.Oct 23 2020
Doctors and biostatisticians at the University of Michigan Rogel Cancer Center have led the development and validation of a staging system to better predict outcomes and inform treatment decisions for men diagnosed with non-metastatic prostate cancer.
Although it is one of the most common cancers worldwide, prostate cancer remains one of the few major cancers for which the familiar, numerical staging system -; ranging from stage 1 to stage 4 -; has not…
-
Noosa News19 hours agoCrucial step in Sea World helicopter crash investigation set
-
Business18 hours agoWhy Accent, DroneShield, EBR Systems, and Titomic shares are pushing higher
-
General15 hours agoForget a tariff-induced recession, Australians have been in recession for two years
-
Business23 hours agoIs the Qantas share price a buy in the tariff ASX stock market volatility?